Filing Details
- Accession Number:
- 0000899243-20-010341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-06 19:34:59
- Reporting Period:
- 2020-04-03
- Accepted Time:
- 2020-04-06 19:34:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283576 | Nicolas Barthelemy | C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-03 | 1,652 | $42.07 | 6,761 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-03 | 2,688 | $99.99 | 4,073 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-03 | 1,652 | $0.00 | 1,652 | $42.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,652 | 2028-05-16 | No | 4 | M | Direct |
Footnotes
- Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on February 28, 2020.
- This option is currently exercisable.